Interview with Harald Stock, CEO, Grünenthal
You arrived at Grünenthal fairly recently, in January of this year. What was it about the company that attracted you to the position? That goes back to 1987, when I…
Address: Heimeranstrasse 35, Munich,Germany
Tel: +49 89 893119-0
FGK clinical research is a full service contract research organisation offering a complete range of clinical development and consulting services to pharmaceutical, biotechnology and medical device companies.With more than 50 highly skilled and experienced people, FGK operates out of Munich on local and global projects, covering clinical studies from phases I to IV. FGK has extensive experience in all major therapeutic areas and clinical research fields, which allows it to effectively design, manage and analyze its clients’ development programs and clinical trials.FGK works with a network of carefully selected partner companies to provide a range of services to complement its own. The company therefore offers monitoring services all over Europe and the US. It is also able to provide you access to and expertise in leading EDC technologies, which helps provide high-quality clinical trial data in the shortest possible time.FGK also provides expertise in global product development and statistical and regulatory compliance in order to assist biotech and medical device companies in the design and execution of adequate clinical studies and global development strategies.
You arrived at Grünenthal fairly recently, in January of this year. What was it about the company that attracted you to the position? That goes back to 1987, when I…
Roche, once a true pharmaceutical company, is now recognized by its capacity to create a unique business model that allowed to become the world’s largest biotech company with truly differentiated…
Having experienced many years at big pharmaceutical companies, you recently moved into the booming biotech sector by joining Biogen Idec in 2007. What made you make such a decision? The…
Your father was the founder of Dr. Franz Köhler Chemie – that carries his name – and was a very well respected doctor among the German medical and pharmaceutical community.…
Why was the time right in 2000 to start Paion, and how did your background and experiences in the pharma industry, academia and consulting help you create the successful company…
One of the biggest recent milestones for Hikma’s global operations must have been the acquisition of Ribosepharm and Thymoorgan in 2007. How successfully have the two companies integrated into the…
You have a wide professional experience that goes from financial adviser to biotechnology entrepreneur, passing through software business and politics. How will all of those different experiences enable you to…
Your interest in bioinformatics has run though your academic career and now into your business career as CEO and founder of Biomax Informatics; what was your vision for the company…
Could you give us a brief introduction to IMS’ business model? What would you say are the main challenges encountered today in the German market for IMS? IMS has been…
Next year Baxter will accomplish its 50th anniversary in Germany. In the context of its celebration, what would you highlight as the main achievements of the company especially since you…
In the last twenty years, Germany has experienced nearly twenty health care reforms. In your opinion, what have been the main reasons for so many changes? The main reason behind…
The DKFZ – German Cancer Research Center – is Germany’s largest cancer research institute with an international recognition recently coroneted with the Nobel Prize to Mr Harald zur Hausen for…
See our Cookie Privacy Policy Here
